TORONTO, ONTARIO--(Marketwire - June 4, 2012) - Gemoscan Canada, Inc. ("Gemoscan" or the "Company") - (TSXV:GES), (MUN:1GE) announces that, effective May 29, 2012, Ms. Ann Hawley is no longer with the Company. Ms. Hawley was Gemoscan's Vice President, Investor Relations. Gemoscan's Board of Directors would like to thank Ms. Hawley for her efforts over the course of her engagement with the Company.
ABOUT GEMOSCAN CANADA, INC.
Gemoscan is an industry leader in food intolerance management and maintains a first-to-market position with Canada wide distribution through select retail partners. Founded in 2003, using its proprietary patented technology Gemoscan develops, owns and markets comprehensive food sensitivity and dietary management solutions for consumers, including the HEMOCODE(TM) Food Intolerance System, a personalized naturopathic nutritional program that promotes well-being. Gemoscan is the first and only provider to commercialize a food intolerance management solution directly to consumers in partnership with retailers, and today offers the most comprehensive services available.
Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange (TSX-V) under the symbol GES and is quoted on the Munich, Frankfurt and Stuttgart Stock Exchanges under the symbol 1GE.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
|
